Debrisoquine, guanethidine, propranolol and human sleep
- 1 January 1971
- journal article
- clinical trial
- Published by Springer Nature in Psychopharmacology
- Vol. 21 (2), 101-110
- https://doi.org/10.1007/bf00572267
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Proposed supplements and amendments to ‘A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects’, the Rechtschaffen & Kales (1968) standardPsychiatry and Clinical Neurosciences, 2001
- CHEESE REACTION DURING DEBRISOQUINE TREATMENTThe Lancet, 1970
- Late Brain Recovery Processes after Drug OverdoseBMJ, 1970
- Overdose of Tricyclic Anti-Depressants and Deductions Concerning their Cerebral ActionThe British Journal of Psychiatry, 1969
- Hallucinations and propranolol.BMJ, 1969
- On the physiological disposition and possible mechanism of the antihypertensive action of debrisoquinBiochemical Pharmacology, 1969
- Autoradiographic Distribution Studies of Adrenergic Blocking Agents. II. 14C‐Propranolol, a β‐Receptor‐Type BlockerActa Pharmacologica et Toxicologica, 1967
- The effect of amphetamine on the sleep cycleElectroencephalography and Clinical Neurophysiology, 1964
- The Effects of Guanethidine on the Noradrenaline Content of the Hypothalamus in the Cat and RatJournal of Pharmacy and Pharmacology, 1963
- THE INHIBITION OF MONOAMINE OXIDASE BY BENZYL AND PHENETHYLGUANIDINES RELATED TO BRETYLIUM AND GUANETHIDINEAnnals of the New York Academy of Sciences, 1963